Addus HomeCare (NASDAQ:ADUS) Price Target Cut to $142.00 by Analysts at Citizens Jmp

Addus HomeCare (NASDAQ:ADUS) had its price objective decreased by Citizens Jmp from $150.00 to $142.00 in a report released on Wednesday,Benzinga reports. Citizens Jmp currently has a market outperform rating on the stock.

A number of other research firms have also commented on ADUS. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a research note on Wednesday, January 21st. Barclays cut their price objective on Addus HomeCare from $112.00 to $102.00 and set an “underweight” rating on the stock in a research note on Wednesday, March 25th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research note on Wednesday, February 25th. Truist Financial set a $135.00 price objective on Addus HomeCare and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Finally, Wall Street Zen lowered Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $132.33.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $96.64 on Wednesday. The business’s 50-day moving average price is $98.01 and its 200-day moving average price is $107.54. Addus HomeCare has a 12 month low of $90.89 and a 12 month high of $124.43. The firm has a market capitalization of $1.80 billion, a price-to-earnings ratio of 17.86, a PEG ratio of 1.36 and a beta of 0.92. The company has a current ratio of 1.83, a quick ratio of 1.80 and a debt-to-equity ratio of 0.08.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, beating analysts’ consensus estimates of $1.52 by $0.10. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm had revenue of $363.50 million for the quarter, compared to analyst estimates of $366.41 million. During the same period last year, the firm posted $1.42 earnings per share. The business’s revenue for the quarter was up 7.7% on a year-over-year basis. Equities research analysts forecast that Addus HomeCare will post 6.21 EPS for the current year.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Darby Anderson sold 396 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total value of $41,722.56. Following the completion of the sale, the executive vice president directly owned 46,246 shares in the company, valued at approximately $4,872,478.56. The trade was a 0.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP David W. Tucker sold 379 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total value of $39,931.44. Following the completion of the sale, the executive vice president owned 10,423 shares of the company’s stock, valued at approximately $1,098,167.28. The trade was a 3.51% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 16,788 shares of company stock valued at $1,785,633 in the last 90 days. Company insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds have recently added to or reduced their stakes in ADUS. Capital Research Global Investors increased its holdings in Addus HomeCare by 22.3% in the fourth quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock worth $157,837,000 after purchasing an additional 268,192 shares in the last quarter. Tributary Capital Management LLC increased its holdings in Addus HomeCare by 114.1% in the third quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock worth $46,974,000 after purchasing an additional 212,192 shares in the last quarter. Freestone Grove Partners LP increased its holdings in Addus HomeCare by 5,035.2% in the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock worth $14,813,000 after purchasing an additional 135,246 shares in the last quarter. 8 Knots Management LLC bought a new stake in shares of Addus HomeCare during the third quarter valued at approximately $6,075,000. Finally, Empowered Funds LLC increased its holdings in shares of Addus HomeCare by 186.1% during the fourth quarter. Empowered Funds LLC now owns 70,927 shares of the company’s stock valued at $7,617,000 after acquiring an additional 46,137 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.

Key Stories Impacting Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Q1 results: Addus reported $1.62 EPS, beating estimates by $0.10 and showing 7.7% year‑over‑year revenue growth; management highlighted profitable growth and solid margins, which supports longer‑term earnings momentum. Addus HomeCare: Q1 Earnings Snapshot
• Positive Sentiment: Geographic expansion: Addus entered Indiana via the HomeCourt acquisition and has another deal lined up — inorganic growth that broadens its footprint and revenue base. This bolsters the company’s roll‑up strategy and near‑term organic growth outlook. Addus Enters Indiana With HomeCourt Acquisition, Lines Up Second Deal
• Positive Sentiment: Personal care strength and call highlights: Management said personal care was the primary growth driver amid flat volumes in some segments; the earnings call emphasized margin expansion and disciplined M&A execution. These are constructive for profitability even if top‑line pacing is mixed. Addus HomeCare Earnings Call Highlights Profitable Growth
• Neutral Sentiment: Investor access: Management will present at BofA and other May investor conferences — increased visibility can help re‑rate the stock if management convinces investors on guidance and M&A cadence. Addus HomeCare to Participate in Upcoming Investor Conferences in May
• Neutral Sentiment: Valuation discussion: Recent writeups highlight a DCF/valuation gap and reappraise upside after the quarter — useful for longer‑term investors but not an immediate catalyst. A Look At Addus HomeCare (ADUS) Valuation After Q1 Earnings Beat And Indiana Acquisitions
• Negative Sentiment: Revenue miss and market reaction: Revenue of $363.5M came in slightly below consensus, and some outlets flag that as the primary reason shares are down as investors focus on near‑term top‑line momentum. Addus HomeCare (NASDAQ:ADUS) Misses Q1 CY2026 Sales Expectations
• Negative Sentiment: Analyst action and selling pressure: Coverage notes and pieces explaining why ADUS is trading lower summarize investor disappointment; Citizens Jmp cut its target from $150 to $142 (still constructive but the cut can weigh on near‑term sentiment). Benzinga Coverage of Analyst Price Target Change
• Negative Sentiment: Market commentary: Several consumer/health outlets and summaries cite the revenue miss and cautious guidance implications as drivers of the decline in ADUS shares today. Why Addus HomeCare (ADUS) shares are trading lower today

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.